高级检索
High percentage of alpha 1-globulin in serum protein is associated with unfavorable prognosis in non-small cell lung cancer

    作者

    Qu, X;Pang, ZF;Yi, WW;Wang, Y;Wang, K;Liu, Q;Du, JJ

    作者单位

    [Qu, Xiao; Pang, Zhaofei; Wang, Ying; Wang, Kai; Liu, Qi; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250021, Peoples R China.;-;[Yi, Weiwei] Shandong Univ, Shandong Prov Hosp, Dept Oncol, Jinan 250021, Peoples R China.;-;[Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Thorac Surg, Jinan 250021, Peoples R China.

    摘要

    The association of the percentage composition of serum protein in patients undergoing lung resections for non-small cell lung cancer (NSCLC) with overall survival and recurrence-free survival has never been investigated. Patients were selected consecutively from the database of the Bio-Bank of Shandong Provincial Hospital. We retrospectively examined the impact of preoperative percentage composition of serum protein detected by serum protein electrophoresis on survival. Furthermore, we investigated the relationships between the potential prognostic biomarkers and clinicopathological factors. A total of 390 patients were evaluated. The higher percentage of alpha 1-globulin in serum protein was significantly associated with histology type (p = 0.001), worse tumor status (p = 0.001) and higher pathological stage (p = 0.004). The alpha 1-globulin percentage composition was an independent prognostic factor for overall survival (hazard ratio 1.52, 95 % CI 1.04-2.23, p = 0.03). High percentage of alpha 1-globulin in serum protein was also related to short recurrence survival (hazard ratio 1.56, 95 % CI 1.14- 2.13, p = 0.005). Our results showed that the percentage of alpha 1-globulin in serum protein may be an independent prognostic factor in NSCLC.

    关键词

    ALPHA-1-ANTITRYPSIN DEFICIENCY; EPITHELIAL-CELLS; CARCINOMA; INHIBITOR; ALPHA-2-MACROGLOBULIN; ELECTROPHORESIS; ADENOCARCINOMA; CLASSIFICATION; GROWTH
基本信息

  • 所属机构:

    归属医师: 衣巍伟 杜贾军 王凯

    PMID:25216870

    UT:000342079600052

    刊名:MEDICAL ONCOLOGY

    年,卷(期):2014年31卷10期

    DOI:10.1007/s12032-014-0238-7

    附件: pdf

    收录:   SCIE